MINNEAPOLIS (Legal Newsline) - Medtronic has defeated a shareholder class action lawsuit that alleged the company hid problems with an insulin pump's FDA approval.
The company received a warning letter on Wednesday related to inadequate quality requirements at the headquarters for its diabetes business. It comes after Medtronic expanded a recall of its MiniMed 600 series insulin pumps.